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Adult-Onset Leukoencephalopathy 
with Axonal Spheroids and 
Pigmented Glia Caused by a Novel 
R782G Mutation in CSF1R
Nicola Foulds1, 2, *, Reuben J. Pengelly2, *, Simon R. Hammans3, James A. R. Nicoll3, 
David W. Ellison4, Adam Ditchfield5, Sarah Beck1 & Sarah Ennis2
We report a new family with autosomal dominant inheritance of a late onset rapidly progressive 
leukodystrophy in which exome sequencing has revealed a novel mutation p.R782G in the Colony-
Stimulating Factor 1 Receptor gene (CSF1R). Neuropathology of two affected family members 
showed cerebral white matter degeneration with axonal swellings and pigmented macrophages. 
The few recently reported families with CSF1R mutations had been previously labelled “hereditary 
diffuse leukencephalopathy with axonal spheroids” (HDLS) and “pigmentary orthochromatic 
leukodystrophy” (POLD), disorders which now appear to form a disease continuum. The term “adult-
onset leukoencephalopathy with axonal spheroids and pigmented glia” (ALSP) has been proposed to 
encompass this spectrum. As CSF1R regulates microglia this mutation implies that dysregulation of 
microglia is the primary cause of the disease.
Adult onset leukodystrophies are a rare group of disorders with significant clinical and pathological het-
erogeneity. Leukodystrophies are characterised pathologically by extensive degenerative and /or demy-
elinating lesions in the cerebral white matter. Clinical manifestations can be very variable including 
behavioural or mood changes, dementia, Parkinsonism, spasticity, dystonia and seizures. Brain MRI 
changes may be helpful in some cases to determine the aetiology of the leukodystrophy, but are not 
always discriminatory. Until recently molecular characterisation of this group of disorders had remained 
elusive, but advances in genetic technologies have allowed significant progress to be made. The last few 
years has seen effective ante-mortem diagnosis in CADASIL (cerebral arteriopathy, autosomal dominant, 
with subcortical infarcts and leukencephalopathy)1,2 (Notch 3 mutations) and CARASIL (cerebral arte-
riopathy, autosomal recessive, with subcortical infarcts and leukencephalopathy)3,4 (HTRA1 mutations) 
and delineation of the autosomal dominant leukodystrophy associated with amplifications of the gene 
LMNB15. Most recently, mutations in the Colony-Stimulating Factor 1 Receptor gene (CSF1R), have 
been associated with causing hereditary diffuse leukencephalopathy with axonal spheroids (HDLS)6,7 and 
pigmentary orthochromatic leukodystrophy (POLD)8. Families reported so far with changes in this gene 
have presented with a mean age of onset in the fourth decade and an average disease course of six to nine 
years6,9. The condition has often presented with a frontal lobe syndrome including lack of social inhibi-
tion and poor judgement, and progressed to involve memory impairment, personality changes, motor 
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impairment and ultimately seizures6,7,9. Neurological signs prominent in several reported individuals 
have been limb apraxia and early loss of speech. So far there have been no reported genotype-phenotype 
correlations with some families showing significant differences in disease presentation and course within 
different family members. Although the majority of families reported to date have shown a clear domi-
nant family history together with a mutation that segregates appropriately, a recent publication has found 
a significant proportion of de-novo CSF1R mutations in their cohort10. It is possible that there has been 
ascertainment bias in families initially investigated for changes in this gene, with convincing dominant 
families constituting the majority. In addition most available data would suggest that mutations in CSF1R 
have a high penetrance for a particularly aggressive phenotype, but there is one reported instance of 
non-penetrance at age 69 years10. The family that we report was typical in that the initial clinical pres-
entation was rather non-specific, but notable in that the disease course was particularly rapid in all three 
affected individuals.
CSF-1R is a cell-surface receptor for the cytokine macrophage colony-stimulating factor 1 (CSF-1), 
which is known to be involved in regulation of differentiation and proliferation of mononuclear phago-
cytic cells, including microglia in the central nervous system. The protein has an intracellular tyrosine 
kinase (TK) domain and an extracellular ligand-binding domain and all HDLS causing mutations have 
thus far been reported in the TK domain (exons 12 to 22). The mutation in the family we report is pres-
ent in exon 18, CSF1R:p.R782G.
Results
Clinical Cases. 1i presented at the age of 40 years with behavioural change and difficulties with her 
legs. The following year she had developed incontinence of urine and reduced fluency of speech and 
was admitted to hospital in status epilepticus. She underwent a brain biopsy which showed degenerative 
changes in the cerebral white matter as described below. An air encephalogram showed cerebellar and 
cerebral atrophy. 1i died a few weeks later, aged 41.
2ii was the index case in this family (Fig. 1). She presented to clinical services at 38years with aching 
limbs. This was first investigated a year later following a fall which injured her left wrist and the pain in 
this arm failed to resolve and became a constant feature. At this time emotional lability and some mem-
ory loss had been noted by family. Her illness progressed rapidly to involve leg weakness and urinary 
incontinence and by the age of 39 years she was using a wheelchair. Aged 40 years she was admitted to 
hospital having had an episode of loss of consciousness and at this time was noted to have very slurred 
speech. MRI brain scans showed extensive white matter disease that was felt to be less confluent than 
that usually seen in a leukodystrophy and less extensive than CADASIL. Further testing showed normal 
evoked potentials and nerve conduction studies and CSF analysis was negative for oligoclonal bands. 2ii 
declined rapidly, lost all speech and died at 40years from bronchopneumonia. Post- mortem examination 
of her brain is described below.
2i presented to clinical services at 57years with slurred speech and difficulty finishing sentences. At 
this time he was complaining of aching limbs, and now found his writing to be clumsy and his walking 
slower and more unsteady. He had also noted some memory loss and his family felt that his personality 
had changed. 2i was working as an agricultural contractor at the time and concerns had been raised by 
a farm manager that he was not safe operating farm machinery and was not performing routine tasks 
appropriately. MRI brain scanning at this time showed volume loss in the frontal and parietal lobes and 
thinning of the corpus callosum. There was also patchy abnormal signal in the white matter of the corpus 
callosum and in both parietal and frontal lobes (Fig. 2). EMG and nerve conduction studies were nor-
mal. Examination showed only minimal limb and gait ataxia, but marked ideomotor and constructional 
Figure 1. Family pedigree: Individuals shown in solid blue are those affected. A diagonal line indicates that 
the individual is now deceased.
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Figure 2. Axial T2-weighted images including the corpus callosum and peri-rolandic white matter. The 
MRI shows multifocal involvement of the corpus callosum with volume loss, particularly posteriorly. There 
is asymmetric white matter involvement with sparing of the sub-cortical u-fibres. White matter deep to the 
pre-central and post-central gyri is specifically involved. No signal change is found within the pyramidal 
tracts more inferiorly. In places there is apparent involvement of white matter lying transverse to the long 
axis of the lateral ventricles. Otherwise there is mild cerebellar volume loss, mild parietal and frontal 
atrophy. The brainstem is normal.
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apraxia. A Mini-Mental State examination indicated a substantial cognitive impairment with particular 
deficits in orientation in time and place and ability to repeat phrases and perform simple arithmetic. His 
condition declined very rapidly with assessment 6 months later revealing almost no speech and limited 
spontaneous movement with poor sitting balance. He had also become incontinent of urine and was 
beginning to struggle with fluids. 2i died 2 months later, aged 59 years having suffered several protracted, 
generalised seizures.
Genetic analysis. Exome sequencing was undertaken on individual 2i. A mean depth of sequencing 
coverage of 54X was attained across targeted exome regions. A total of 24,755 variants were called for 
this individual; the data passed all standard quality checks. A heterozygous non-synonymous c.C2344G 
variant resulting in p.R782G was observed in exon 18 of the CSF1R gene (defined according to RefSeq 
transcript NM_005211). This variant was confirmed by Sanger sequencing in an NHS CPA accredited 
laboratory. This variant is not found in dbSNP 138 or in a public repository of exome data from 6500 
individuals (http://evs.gs.washington.edu/EVS/) and was designated as novel to this patient.
Neuropathology. Case 2ii. Macroscopic examination. External examination of the brain showed 
mild cerebral atrophy, most prominent in the frontal lobes. Coronal sections showed atrophy of the 
corpus callosum and patchy discolouration of the centrum semiovale with poorly defined areas of grey 
granularity around the apices of the lateral ventricles (Fig.  3a). The brainstem was atrophic with the 
rostro-caudal tracts being prominently affected. The cerebellar hemispheres were atrophied. The spinal 
cord appeared macroscopically normal.
Histological examination. Degenerative changes were present in the white matter involving predomi-
nantly cerebral white matter (Fig. 3b), particularly in the centrum semiovale and corpus callosum with 
relative sparing of subcortical u-fibres, corticospinal tracts in the brainstem (Fig. 3c) and in the spinal 
cord the crossed and uncrossed corticospinal tracts and the dorsal columns (Fig. 3d). The abnormality 
consisted of severe loss of myelinated fibres with scattered pigment-containing macrophages (Fig. 3e,f) 
and occasional axonal spheroids (Fig. 3g). Macrophages were also present in otherwise apparently nor-
mal cerebral white matter (Fig.  3h,i). Ramified microglia were largely absent from the affected white 
matter, but were present with a normal density and morphology in the grey matter (Fig. 3j). There were 
occasional dysmorphic neurons in the cerebral cortex, (Fig. 3k), particularly in the deeper laminae, but 
the grey matter was relatively normal elsewhere. Ultrastructural examination revealed lamellar bod-
ies and fingerprint-like profiles in the macrophages within affected areas. At the time, the pathological 
process was interpreted as a leukodystrophy associated with neuroaxonal dystrophy, with features most 
consistent with adult pigmentary sudanophilic leukodystrophy.
Case 1i. Essentially identical histological features to those described above ( Case 2ii), including deple-
tion of myelinated fibres, pigmented macrophages and axonal spheroids, were identified in a biopsy of 
affected cerebral white matter. A similar pattern of macrophages within the lesion is illustrated (Fig. 3l).
Discussion
The striking clinical and pathological similarities between the hereditary white matter diseases HDLS 
and POLD have been noted for several years11, but until recently a definitive molecular link between the 
two disorders had not been made. In 2012 Rademakers et al. reported fourteen families with HDLS in 
whom a combination of linkage analysis and exome sequencing had revealed mutations in the tyrosine 
kinase domain of CSF1R .Functional studies suggested that the mutations affect the kinase activity of the 
protein, probably altering the phosphorylation of downstream targets. In addition the authors speculated 
that the mutant CSF1R might assemble into non functional homodimers and wildtype-mutant heterod-
imers inducing a dominant negative disease mechanism. This gene codes for a cell-surface receptor 
involved in the regulation of survival, and differentiation of mononuclear phagocytic cells, including 
microglia in the central nervous system. The key role for CSF1 in maintaining the microglial population 
has recently been highlighted by the observation that administration of CSF1 antibody can reversibly 
deplete CNS microglia in rodent models12. The discovery of CSF1R mutations added HDLS to the emerg-
ing class of primary microglial disorders that have been termed microgliopathies. Of particular note, we 
identified macrophages in otherwise apparently normal cerebral white matter (case 2ii), consistent with 
a primary role for macrophages/microglia in causing the lesions as indicated by the genetics.
More recently, by sequencing two biopsy proven families, Rademakers’ group have confirmed that 
mutations in CSF1R also underlie POLD. Indeed, not only are the mutations in the same domain of the 
gene as those found in HDLS families, one mutation was in fact the same as that previously reported 
with this pathology8. The unifying term “adult-onset leukoencephalopathy with axonal spheroids and 
pigmented glia” has been proposed to encompass this disease spectrum11.
We report a family with a novel mutation in CSF1R and a particularly rapid disease course with pres-
entation to death occurring within two to three years in all three family members. The mutation that we 
report changes the same amino acid position as that reported by Kinoshita et al.7 in an HDLS family and 
more recently by Nicholson et al.8 in a POLD family. The mutation reported in both of these previous 
families changes an arginine to a histidine at position 782 of the protein. This position is strongly con-
served between species and within members of the CSF1/platelet derived growth factor family of tyrosine 
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kinase. Previous authors have discussed the likely mechanism of action of HDLS/POLD mutations being 
a reduction in autophosphorylation of the kinase domain. After binding to the CSF1 ligand, CSF1R is 
believed to form homodimers before autophosphorylation of its kinase domain. This autophosphoryla-
tion precedes CSF1R-dependent phosphorylation of downstream targets, meaning that CSF-1 signaling 
is critically dependant on this.
We have not performed functional validation for the R782G mutation identified in this family; there is 
therefore a possibility that this variant is not pathogenic. However, Nicholson et al.8 showed that CSF1R 
Figure 3. Case 2ii. Post mortem neuropathology. (a) Coronal section of cerebrum showing granular 
degeneration of deep white matter (arrow). (b) Low power histology of frontal lobe showing extensive 
degeneration of deep cerebral white matter (arrow) and corpus callosum with relative sparing of subcortical 
white matter (LFB/Nissl). Similar degenerative changes affected the corticospinal tracts in the brainstem 
(c. midbrain, arrows) and corticospinal tracts and dorsal columns in the spinal cord (d. arrows) (LFB/
Nissl). Affected cerebral white matter showed severe depletion of myelinated fibres (e. LFB/Nissl) with 
pigmented macrophages (e, arrow and f. CD68 immunohistochemistry) and scattered axonal swellings 
(g. arrow, neurofilament immunohistochemistry). Apparently normal subcortical white matter had 
preserved myelinated fibres (h. LFB/Nissl) but still had an abnormal population of macrophages (i. CD68 
immunohistochemistry). Despite the CSF1R mutation, microglia and perivascular macrophages in the grey 
matter appeared morphologically normal (j. CD68 immunohistochemistry). The deep layers of the cerebral 
cortex contained morphologically abnormal, swollen neurons (k. neurofilament immunohistochemistry). 
Case 1i. Similar histological features, including a similar distribution of macrophages, were present in 
affected cerebral white matter in the biopsy sample (l. CD68 immunohistochemistry). Figures e-f all taken 
with x20 objective, scale bar shown in fig e = 100 μm.
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harbouring the R782H mutation lacks detectable autophosphorylation following activation in cyto. In 
light of this, we consider that it is highly likely that the more severe R782G amino acid change we observe 
is also pathogenic through the same mechanism. Arginine and histidine would have a similar charge at 
neutral pH, but substitution to a glycine would increase the negative charge at this locus and this may 
potentially provide an explanation for the apparently more severe disease course. Addition of a more 
polar amino acid at position 782 may have a more deleterious effect on this process. It should also be 
considered that this family may carry an additional mutation or polymorphism elsewhere in the genome 
that may affect disease progression, or may have been subject to an adverse environmental influence that 
accounts for the particularly rapid disease course that family members have experienced.
In many individual instances of adult onset leukodystrophy the combination of clinical and MRI 
brain features are not specific enough for confident clinical diagnoses to be made without further specific 
testing. In the past families have often had to wait for post mortem findings to understand further which 
disease process has been involved, and what the broader family risk may be. For some leukodystrophies 
improvements in MRI scanning and interpretation have allowed the delineation of diagnostic algorithms 
that pinpoint the likely underlying mechanism and often the specific gene13, but for HDLS and POLD, 
MRI and clinical features have thus far often not been recognised as these specific entities, and a wide 
variety of ante-mortem diagnoses have been considered6,9. For family member 2i in this report loss of 
volume in the corpus callosum, frontal and parietal white matter, together with T2 hyperintensities in the 
same regions were seen. These changes were apparent at a point in the patients’ disease course at which 
clinical features were rather non specific (memory loss, personality change and unsteadiness) and would 
not necessarily have pointed to a white matter disorder. This pattern of changes is certainly in keeping 
with descriptions of previous patients with HDLS and POLD and it may be that in time a sequence of 
signature changes will be recognisable. However, as with many areas of adult and paediatric neurology in 
which a great variety of different genes can underlie very similar clinical and radiological presentations, 
molecular genetics may provide the fastest route forward. It is likely that there will be increasing use 
of rapid, panel-based, DNA testing for diagnosing disorders that lack specific clinical signatures, or for 
which, as yet, the clinical signature has not been elucidated. The ability to provide antemortem diagno-
ses for individuals and families in such circumstances will improve the prognostic information that can 
be provided, and in the future may allow more specific treatments. In addition, a molecular result will 
allow for clarification of the broader family risk where this is desired, and for predictive genetic testing 
in younger members.
Methods
Genetic analysis. DNA was available for individual 2i, isolated from peripheral blood lymphocytes. 
Exome enrichment was performed using the SureSelect Human All Exon V5.0 kit (Agilent), prior to 
sequencing on the Illumina HiSeq 2000 system. Following sequencing, reads were aligned to reference 
genome GRCh37 (hg19) using NovoAlign v2.08.02 (http://www.novocraft.com/products/novoalign/), 
with duplicate reads flagged using Picard (http://broadinstitute.github.io/picard/). Depth of coverage for 
target regions was assessed using BEDTools v2.17 14. Following alignment, variants were called using 
SAMtools v0.1.18 15.
Called variants were annotated with functional effect predictions and population allele-frequencies 
using ANNOVAR v2013Feb21 16. Sample provenance was ensured through independent application of a 
SNP based identity panel 17. We performed a tiered analysis of quality filtered variant data, interrogating 
strong candidate genes in the first instance (namely CSF1R and LMNB1).
No historical DNA samples of sufficient quality were available from family members 1i or 2ii to look 
for the p.R782G CSF1R change.
Neuropathology. The formalin fixed brain and spinal cord from 2ii were examined macroscopically 
and sampled extensively for histology. Sections were stained with haematoxylin & eosin and luxol fast 
blue/Nissl and selected sections were immunostained for neurofilament, PGM1, GFAP and ubiquitin. A 
similar analysis was performed on the brain biopsy from 1i.
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